Chief Medical Officer
ASC Therapeutics
Milpitas, California, United States
Chief Medical Officer at ASC Therapeutics. Former CMO at Symvivo, Myriad Genetics/Crescendo Bioscience and CellMax Life. Vice President at Becton Dickinson and Global Medical Head for Abbott/AbbVie (Immunology - Humira). Consulting Medical Officer / SME at AveXis-Novartis, uniQure, Bellicum.
Holding a tenured Professorship of Immunology at the University of Leon, Spain. Received PhD from the University of Wuerzburg, Germany and MD from the University of Salamanca, Spain
Physician, immunologist and molecular biologist with extensive global leadership experience in clinical research and development, translational medicine, business development and medical affairs. Led the clinical strategy for multiple CBER/CDER meetings and submissions (pre-IND through NDA) for FDA, EMA and China's NMDA.
Medical, scientific, academic, industry and consulting career focused on gene therapy, gene editing, CRISPR, stem cell therapy for hematology and immuno-oncology, biological therapies for cancer, inflammatory diseases and rheumatology, including personalized medicine, genomic and cellular biomarkers. Other therapeutic areas of expertise are neurology, cardiovascular and metabolic diseases.
Author and co-author of over 100 peer-reviewed publications, including Nature, Lancet, Journal of Immunology and Journal of Experimental Medicine, books and medical articles and member of several scientific and medical societies.
Board Member of the Forbes Technology Council. Member of several scientific and medical societies, including ASGCT, ISSCR, ISTH, ASCO, ASH, ESMO, AACR, SITC and ISPOR.
Sunday, June 25, 2023
18:30 – 19:30 ET